[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334531-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334531-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","construction-of-disuldptosis-based-immune-response-prediction-model-with-articial-intelligence-and-validation-of-the-pivotal-grouping-oncogene-c-met-in-regulating-t-cell-exhaustion","Construction of disulﬁdptosis-based immune response prediction model with artiﬁcial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion","","Research investigates disulﬁdptosis in pan-cancer by clarifying its role in cancer immunity and constructing an artificial-intelligence–driven prognosis framework. Gene signatures linked to disulﬁdptosis were derived using TCGA, ICGC, CGGA, and multiple GEO cohorts with Cox regression, LASSO, and multivariate Cox analyses. SsGSEA, CIBERSORT, correlation analyses, and WGCNA supported mapping between disulﬁdptosis and immune infiltration, including T cell exhaustion. Machine learning defined glioma-specific DSP clusters for survival and immunotherapy response, and c-MET was validated as a tumor driver and immune regulator, reducing PD1+ CD8+ T-cell proportions upon c-MET down-regulation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/construction-of-disuldptosis-based-immune-response-prediction-model-with-articial-intelligence-and-validation-of-the-pivotal-grouping-oncogene-c-met-in-regulating-t-cell-exhaustion/334531/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/construction-of-disuldptosis-based-immune-response-prediction-model-with-articial-intelligence-and-validation-of-the-pivotal-grouping-oncogene-c-met-in-regulating-t-cell-exhaustion/334531.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding disulﬁdptosis and cancer immunity?","Question",{"text":63,"@type":64},"The study aims to dissect disulﬁdptosis’s role across pan-cancer and explore its crosstalk with cancer immunity, then use this to build prediction models for prognosis and immunotherapy response.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were disulﬁdptosis-related gene signatures and prognosis models constructed?",{"text":68,"@type":64},"The approach uses TCGA, ICGC, CGGA, and GEO datasets with univariate Cox regression, LASSO regression, and multivariate Cox regression to create a rough gene signature, then applies SsGSEA/CIBERSORT, correlation analyses, WGCNA, and machine learning to refine the prognosis model, including a customized model for glioma.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does c-MET play in glioma immune regulation according to the study?",{"text":72,"@type":64},"c-MET is validated as a tumor driver gene and as a regulator in the JAK3-STAT3-PD-L1/PD1 axis in glioma and T cells; down-regulation of c-MET decreases the proportion of PD1+ CD8+ T cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334531,1790821487,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","TYPE Original Research PUBLISHED 26 January 2024  \nDOI 10.3389/fimmu.2024.1258475  \nOPEN ACCESS  \nEDITED BY  \nTakaji Matsutani, Maruho, Japan  \nREVIEWED BY  \nSilvia D’Amico,  \nNational Research Council (CNR), Italy Xiufei Chen,  \nUniversity of Oxford, United Kingdom  \n*CORRESPONDENCE Haigang Jin  \n[jhgwzxshp@163.com](jhgwzxshp@163.com)[ ](jhgwzxshp@163.com)Zhenyu Wang  \n[wzyxshp@163.com](wzyxshp@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 14 July 2023  \nACCEPTED 04 January 2024  \nPUBLISHED 26 January 2024  \nCITATION  \nLi P, Wang S, Wan H, Huang Y, Yin K, Sun K, Jin H and Wang Z (2024) Construction of disulﬁdptosis-based immune response prediction model with artiﬁcial intelligence and validation of the pivotal grouping  \noncogene c-MET in regulating T cell exhaustion.  \nFront. Immunol. 15:1258475 .  \ndoi: 10.3389/fimmu.2024.1258475  \nCOPYRIGHT  \n© 2024 Li, Wang, Wan, Huang, Yin, Sun, Jin and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nConstruction of disulﬁdptosisbased immune response prediction model with artiﬁcial intelligence and validation of the pivotal grouping oncogene c-MET in regulating  \nT cell exhaustion  \nPengping Li 1†, Shaowen Wang 2†, Hong Wan 3†, Yuqing Huang 1, Kexin Yin 1, Ke Sun 1, Haigang Jin 1* and Zhenyu Wang 1*  \n1 Department of Thyroid and Breast Surgery, The First People’s Hospital of Xiaoshan District, Xiaoshan Afﬁliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China, 2 Neuromedicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China, 3 Department of General Surgery, Breast Surgery, The First Afﬁliated Hospital of Anhui Medical University,  \nHefei, China  \nBackground: Given the lack of research on disulﬁdptosis, our study aimed to dissect its role in pan-cancer and explore the crosstalk between disulﬁdptosisand cancer immunity.  \nMethods: Based on TCGA, ICGC, CGGA, GSE30219, GSE31210, GSE37745, GSE50081, GSE22138, GSE41613, univariate Cox regression, LASSO regression, and multivariate Cox regression were used to construct the rough gene signature based on disulﬁdptosis for each type of cancer. SsGSEA and Cibersort, followed by correlation analysis, were harnessed to explore the linkage between disulﬁdptosis and cancer immunity. Weighted correlation network analysis (WGCNA) and Machine learning were utilized to make a reﬁned prognosis model for pan-cancer. In particular, a customized, enhanced prognosis model was made for glioma. The siRNA transfection, FACS, ELISA, etc., were employed to validate the function of c-MET.  \nResults: The expression comparison of the disulﬁdptosis-related genes (DRGs) between tumor and nontumor tissues implied a signiﬁcant difference in most cancers. The correlation between disulﬁdptosis and immune cell inﬁltration, including T cell exhaustion (Tex), was evident, especially in glioma. The 7-gene signature was constructed as the rough model for the glioma prognosis. A pancancer suitable DSP clustering was made and validated to predict the prognosis. Furthermore, two DSP groups were deﬁned by machine learning to predict the survival and immune therapy response in glioma, which was validated in CGGA. PD-L1 and other immune pathways were highly enriched in the core blue gene module from WGCNA. Among them, c-MET was validated as a tumor driver gene and JAK3-STAT3-PD-L1/PD1 regulator in glioma and T cells. Speciﬁcally, the down-regulation of c-MET decreased the proportion of PD1+ CD8+ T cells.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusion: To summarize, we dissect","cbCaituJu6um9ACw","https://ap.wps.com/l/cbCaituJu6um9ACw","pdf",16557089,18,"English","# Background\n## Regulated cell death and disulﬁdptosis\n# Methods\n## Data sources and gene signature construction\n## Immune association analysis\n## Prognosis model building and validation\n# Results\n## Differential expression of disulﬁdptosis-related genes\n## Links to immune cell infiltration and T-cell exhaustion\n## DSP clustering and predictive outcomes in glioma\n## c-MET validation and immune regulation","[{\"question\":\"What is the study’s main goal regarding disulﬁdptosis and cancer immunity?\",\"answer\":\"The study aims to dissect disulﬁdptosis’s role across pan-cancer and explore its crosstalk with cancer immunity, then use this to build prediction models for prognosis and immunotherapy response.\"},{\"question\":\"How were disulﬁdptosis-related gene signatures and prognosis models constructed?\",\"answer\":\"The approach uses TCGA, ICGC, CGGA, and GEO datasets with univariate Cox regression, LASSO regression, and multivariate Cox regression to create a rough gene signature, then applies SsGSEA/CIBERSORT, correlation analyses, WGCNA, and machine learning to refine the prognosis model, including a customized model for glioma.\"},{\"question\":\"What role does c-MET play in glioma immune regulation according to the study?\",\"answer\":\"c-MET is validated as a tumor driver gene and as a regulator in the JAK3-STAT3-PD-L1/PD1 axis in glioma and T cells; down-regulation of c-MET decreases the proportion of PD1+ CD8+ T cells.\"}]","Construction of disulﬁdptosis-based immune response prediction model with artiﬁcial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion | PDF",1790007086,45]